Development and validation of a mass spectrometry binding assay for mGlu5 receptor

Archive ouverte

Ricart-Ortega, Maria | Berizzi, Alice | Catena, Juanlo | Malhaire, Fanny | Muñoz, Lourdes | Serra, Carmen | Lebon, Guillaume | Goudet, Cyril | Llebaria, Amadeu

Edité par CCSD ; Springer Verlag -

International audience. Mass spectrometry (MS) binding assays are a label-free alternative to radioligand or fluorescence binding assays, so the readout is based on direct mass spectrometric detection of the test ligand. The study presented here describes the development and validation of a highly sensitive, rapid, and robust MS binding assay for the quantification of the binding of the metabotropic glutamate 5 (mGlu5) negative allosteric modulator (NAM), MPEP (2-methyl-6-phenylethynylpyridine) at the mGlu5 allosteric binding site. The LC-ESI-MS/MS (liquid chromatography-electrospray ionization-tandem mass spectrometric) analytical method was established and validated with a deuterated analogue of MPEP as an internal standard. The developed MS binding assay described here allowed for the determination of MS binding affinity estimates that were in agreement with affinity estimates obtained from a tritiated MPEP radioligand saturation binding assay, indicating the suitability of this methodology for determining affinity estimates for compounds that target mGlu5 allosteric binding sites.

Suggestions

Du même auteur

Mechanistic insights into light-driven allosteric control of GPCR biological activity

Archive ouverte | Ricart-Ortega, Maria | CCSD

International audience. G protein-coupled receptors (GPCR), including the metabotrobic glutamate 5 receptor (mGlu5), are important therapeutic targets and the development of allosteric ligands for targeting GPCRs ha...

Agonists and allosteric modulators promote signaling from different metabotropic glutamate receptor 5 conformations

Archive ouverte | Nasrallah, Chady | CCSD

International audience. Metabotropic glutamate receptors (mGluRs) are dimeric G-protein-coupled receptors activated by the main excitatory neurotransmitter, L-glutamate. mGluR activation by agonists binding in the v...

Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator

Archive ouverte | Font, Joan | CCSD

International audience. Light-operated drugs constitute a major target in drug discovery, since they may provide spatiotemporal resolution for the treatment of complex diseases (i.e. chronic pain). JF-NP-26 is an in...

Chargement des enrichissements...